Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRELI domain containing 2 (PRELID2) is a protein coding gene in humans, predominantly recognized for its predicted function in phosphatidic acid transfer activity and involvement in phospholipid transport within the mitochondrial intermembrane space[4][6]. As a member of the PRELI/MSF1 domain-containing protein family, PRELID2 is evolutionarily conserved and implicated in mitochondrial lipid metabolism, a process crucial for maintaining cellular energy homeostasis and membrane dynamics[2][4]. Functional studies on the PRELI-like family suggest roles in embryogenesis, lymphocyte differentiation, and stress responses, with recent evidence indicating its association with cancer progression, including potential contributions to radiotherapy resistance and tumor microenvironment adaptation[2][6]. No directly approved drugs or therapeutics specifically target PRELID2, although family members are of interest as potential cancer biomarkers and future therapeutic targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PRELI domain containing 2 (PRELID2).